Gambia vs Mali: Death rate from Parkinson's disease
Gambia
1.16 deaths per 100,000 people
in 2021
Mali
1.15 deaths per 100,000 people
in 2021
Gambia rank
158th
Mali rank
161st
Death rate from Parkinson's disease over time
- Gambia
- Mali
How they compare
Gambia currently reports 1.16 deaths per 100,000 people against 1.15 deaths per 100,000 people in Mali, a difference of 0.01 deaths per 100,000 people.
Across all 22 years both countries report, Gambia has been ahead every year.
Gambia ranks 158th and Mali ranks 161st of 194 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6 deaths per 100,000 people | 1.31 deaths per 100,000 people | 0.297 deaths per 100,000 people | Gambia |
| 2010s | 1.32 deaths per 100,000 people | 1.23 deaths per 100,000 people | 0.09 deaths per 100,000 people | Gambia |
| 2020s | 1.23 deaths per 100,000 people | 1.19 deaths per 100,000 people | 0.035 deaths per 100,000 people | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Gambia or Mali?
- Gambia, at 1.16 deaths per 100,000 people against 1.15 deaths per 100,000 people in Mali as of 2021.
- What is the difference in death rate from parkinson's disease between Gambia and Mali?
- 0.01 deaths per 100,000 people, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mali?
- 22 years are reported by both, from 2000 to 2021.
- How do Gambia and Mali rank globally for death rate from parkinson's disease?
- Gambia ranks 158th and Mali ranks 161st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.